183 related articles for article (PubMed ID: 34013552)
1. Sustained IL-4 priming of macrophages enhances the inflammatory response to TLR7/8 ligand R848.
Banete A; Gee K; Basta S
J Leukoc Biol; 2022 Feb; 111(2):401-413. PubMed ID: 34013552
[TBL] [Abstract][Full Text] [Related]
2. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
3. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).
Jirmo AC; Daluege K; Happle C; Albrecht M; Dittrich AM; Busse M; Habener A; Skuljec J; Hansen G
J Immunol; 2016 Dec; 197(11):4219-4227. PubMed ID: 27799314
[TBL] [Abstract][Full Text] [Related]
4. IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells.
Sriram U; Xu J; Chain RW; Varghese L; Chakhtoura M; Bennett HL; Zoltick PW; Gallucci S
PLoS One; 2014; 9(1):e87668. PubMed ID: 24489947
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
Ye J; Mills BN; Qin SS; Garrett-Larsen J; Murphy JD; Uccello TP; Han BJ; Vrooman TG; Johnston CJ; Lord EM; Belt BA; Linehan DC; Gerber SA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851308
[TBL] [Abstract][Full Text] [Related]
6. Differential TLR7-mediated cytokine expression by R848 in M-CSF- versus GM-CSF-derived macrophages after LCMV infection.
Alothaimeen T; Trus E; Basta S; Gee K
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33331816
[TBL] [Abstract][Full Text] [Related]
7. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium.
Asami T; Ishii M; Fujii H; Namkoong H; Tasaka S; Matsushita K; Ishii K; Yagi K; Fujiwara H; Funatsu Y; Hasegawa N; Betsuyaku T
Mediators Inflamm; 2013; 2013():264260. PubMed ID: 24191131
[TBL] [Abstract][Full Text] [Related]
8. IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages.
Pirhonen J; Sirén J; Julkunen I; Matikainen S
J Leukoc Biol; 2007 Nov; 82(5):1185-92. PubMed ID: 17684041
[TBL] [Abstract][Full Text] [Related]
9. R848, a Toll-like receptors 7 and 8 agonist, a potential therapy for allergic rhinitis patients.
Boghdadi G; Hammad N; Amer A; Sammour S; Sorour S
Inflamm Allergy Drug Targets; 2014; 13(2):144-9. PubMed ID: 24773332
[TBL] [Abstract][Full Text] [Related]
10. TLR4, TLR7/8 agonist-induced miR-146a promotes macrophage tolerance to MyD88-dependent TLR agonists.
Nahid MA; Benso LM; Shin JD; Mehmet H; Hicks A; Ramadas RA
J Leukoc Biol; 2016 Aug; 100(2):339-49. PubMed ID: 26908827
[TBL] [Abstract][Full Text] [Related]
11. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
13. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.
Grela F; Aumeunier A; Bardel E; Van LP; Bourgeois E; Vanoirbeek J; Leite-de-Moraes M; Schneider E; Dy M; Herbelin A; Thieblemont N
J Immunol; 2011 Jan; 186(1):284-90. PubMed ID: 21131420
[TBL] [Abstract][Full Text] [Related]
14. Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis.
Jha A; Thwaites RS; Tunstall T; Kon OM; Shattock RJ; Hansel TT; Openshaw PJM
J Allergy Clin Immunol; 2021 Feb; 147(2):694-703.e12. PubMed ID: 32717253
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
16. TLR9 and TLR7/8 activation induces formation of keratic precipitates and giant macrophages in the mouse cornea.
Chinnery HR; Leong CM; Chen W; Forrester JV; McMenamin PG
J Leukoc Biol; 2015 Jan; 97(1):103-10. PubMed ID: 25416814
[TBL] [Abstract][Full Text] [Related]
17. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment.
Seki R
J Immunol Res; 2017; 2017():9653793. PubMed ID: 29181417
[TBL] [Abstract][Full Text] [Related]
19. TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen.
Reuter S; Dehzad N; Martin H; Böhm L; Becker M; Buhl R; Stassen M; Taube C
J Immunol; 2012 May; 188(10):5123-31. PubMed ID: 22491246
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.
Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL
Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
